Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

65.68
+0.92001.42%
Post-market: 65.680.00000.00%16:24 EDT
Volume:49.06K
Turnover:3.21M
Market Cap:93.58M
PE:- -
High:66.32
Open:65.40
Low:64.42
Close:64.76
52wk High:68.00
52wk Low:36.00
Shares:1.42M
Float Shares:1.42M
Volume Ratio:1.63
T/O Rate:3.44%
Dividend:0.65
Dividend Rate:0.99%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Inc Stock (MRNA) Moved Down by 5.13% on Aug 24: A Full Analysis

TradingKey
·
Aug 25

U.S. Court Orders Guardant to Pay $245 Million in DNA Sequencing Patent Dispute

Reuters
·
Aug 25

Moderna is Betting Big on Its Cancer Vaccine. This is What Wall Street Wants to See.

Dow Jones
·
Aug 24

Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances

TIPRANKS
·
Aug 24

Sector Update: Healthcare

MT Newswires Live
·
Aug 24

U.S. Stocks on the MOVE-Jersey Mike's Sub, Moderna, PDD Holding

Reuters
·
Aug 24

Analysts Conflicted on These Healthcare Names: Natera (NTRA), Healthequity (HQY) and CSPC Pharmaceutical Group (OtherCHJTF)

TIPRANKS
·
Aug 24

Guardant Health Loses $245.2 Million Patent Infringement Case

MT Newswires Live
·
Aug 24

Regenxbio reports FDA placed clinical hold on RGX-121

TIPRANKS
·
Aug 24

Barclays Raises Moderna PT on 'transformative' Melanoma Vaccine Potential

Reuters
·
Aug 24

Twinstrand: Court Awards Co and Uw over $245.2 Mln in Damages, Accrued Royalties & Interest for Infringement That Occurred Through May 31, 2026

THOMSON REUTERS
·
Aug 24

Twinstrand: Delaware Court Enters Judgment on Aug. 21 in Favor of Co & University of Washington in Patent Infringement Suit Against Guardant Health

THOMSON REUTERS
·
Aug 24

Twinstrand: Under Judgment, Guardant Health Must Provide Co & Uw with Quarterly Accounting of All U.S. Sales of 11 Guardant Health Products & Services

THOMSON REUTERS
·
Aug 24

Twinstrand: Court Preserves 2023 Willful Infringement Verdict & Orders 6% Royalty on Sales of 11 Guardant Health Products & Services

THOMSON REUTERS
·
Aug 24

Barclays Adjusts Price Target on Moderna to $125 From $48

MT Newswires Live
·
Aug 24

Moderna price target raised to $125 from $48 at Barclays

TIPRANKS
·
Aug 24

BUZZ-US Stocks Weekly: Rate Rattle

Reuters
·
Aug 24

24H | Tesla, Nvidia Jump 1% Each; Strategy Rises 2%; Alibaba Falls 2% as It Plans $10 Billion Hong Kong Share Placement; AAOI Tumbles 10%

US Overnight
·
Aug 24

Hype for Moderna's Cancer Vaccine is Running Ahead of the Math - Heard on the Street

Dow Jones
·
Aug 23

Moderna (MRNA) Posts First Late Stage mRNA Cancer Vaccine Win In Melanoma

Simply Wall St.
·
Aug 23